Kleiner Perkins Caufield & Byers
Kleiner Perkins Caufield & Byers (KPCB) is committed to helping entrepreneurs build sustainable technology businesses. For over 30 years, KPCB has invested in hundreds of market-defining ventures, many of which have gone public or achieved success through mergers and acquisitions. The firm focuses on new technologies and new applications of technology that will drive high-impact change.
KPCB backed companies include Amazon.com, Citrix, Compaq Computer, Electronic Arts, Genentech, Genomic Health, Genprobe, Google, Hybritech, IDEC Pharmaceuticals, Intuit, Netscape, Ligand Pharmaceuticals, Lotus, Nuvasive, Sun Microsystems, Symantec, Verisign and Xilinx.
Additional information can be found at: www.kpcb.com.
For more than 30 years InterWest Partners (www.interwest.com) has partnered with exceptional entrepreneurs to build winning technology and life sciences companies. With more than 200 years of combined operating and investing experience, InterWest’s team has raised $2.8B, completed more than 70 IPOs, and participated in nearly 60 upside acquisitions. Currently investing InterWest X, a $650M fund, the firm continues to believe that providing capital is just the beginning of a long-term collaboration with entrepreneurs to turn their vision into a thriving company.
Interwest Partners has played a formative role in the success of more than 200 companies, including Anesiva, formerly Corgentech, Aspreva, CIENA, Copper Mountain Networks, Corixa, acquired by GlaxoSmithKline PLC, Cor Therapeutics, Crystal Semiconductor, Cyrix, Epicor Medical, IntraLase, Lightera, Myogen, PlaceWare, Silicon Graphics, SiTera, Spinal Dynamics, Stratacom, TheraSense, Ventritex and Xilinx.
Additional information can be found at: www.interwest.com